systhiperСистемные гипертензииSystemic Hypertension2075-082X2542-2189LLC «ИнтерМедсервис»systhiper-129Research ArticleСТАТЬИARTICLESПериндоприл в лечении артериальной гипертензии у пациентов группы высокого рискаНедогодаС. В.noemail@neicon.ruВолгоградский государственный медицинский университетRussian Federation200823122022521215Copyright © Недогода С.В., 20222022Недогода С.В.Недогода С.В.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.syst-hypertension.ru/jour/article/view/129ReferencesFerrari R, Pasanisi G, Notarstefano P et al. Angiotensin-converting enzyme inhibition in cardiovascular disease: evidence with perindopril. Expert Rev Cardiovasc Ther 2005; 3: 15-29.Ferrari R, Pasanisi G, Notarstefano P et al. Angiotensin-converting enzyme inhibition in cardiovascular disease: evidence with perindopril. Expert Rev Cardiovasc Ther 2005; 3: 15-29.Dahlof B, Sever PS, Poulter NR et al. ASCOT Investigators. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet 2005; 366: 895-906.Dahlof B, Sever PS, Poulter NR et al. ASCOT Investigators. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet 2005; 366: 895-906.Hughes AD, Thurston H, O'Rourke M. CAFE Investigators; Anglo-Scandinavian Cardiac Outcomes Trial Investigators; CAFE Steering Committee and Writing Committee. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 2006; 113: 1213-25.Hughes AD, Thurston H, O'Rourke M. CAFE Investigators; Anglo-Scandinavian Cardiac Outcomes Trial Investigators; CAFE Steering Committee and Writing Committee. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 2006; 113: 1213-25.Berthet K, Neal BC, Chalmers JP et al. Perindopril Protection Against Recurrent Stroke Study ollaborative Group. Reductions in the risks of recurrent stroke in patients with and without diabetes: the PROGRESS Trial. Blood Press 2004; 13: 7-13.Berthet K, Neal BC, Chalmers JP et al. Perindopril Protection Against Recurrent Stroke Study ollaborative Group. Reductions in the risks of recurrent stroke in patients with and without diabetes: the PROGRESS Trial. Blood Press 2004; 13: 7-13.Ceconi C, Fox KM, Remme WJ et al. EUROPA Investigators; PERTINENT Investigators and the Statistical Committee. ACE inhibition with perindopril and endothelial function. Results of a substudy of the EUROPA study: PERTINENT. Cardiovasc Res 2007; 73: 237-46.Ceconi C, Fox KM, Remme WJ et al. EUROPA Investigators; PERTINENT Investigators and the Statistical Committee. ACE inhibition with perindopril and endothelial function. Results of a substudy of the EUROPA study: PERTINENT. Cardiovasc Res 2007; 73: 237-46.Ghiadoni L, Magagna A, Versari D et al. Different effect of antihypertensive drugs on conduit artery endothelial function. Hypertension 2003; 41: 1281-6.Ghiadoni L, Magagna A, Versari D et al. Different effect of antihypertensive drugs on conduit artery endothelial function. Hypertension 2003; 41: 1281-6.Jerums G, Allen TJ, Campbell DJ et al. Melbourne Diabetic Nephropathy Study Group. Long-term renoprotection by perindopril or nifedipine in non-hypertensive patients with type 2 diabetes and microalbuminuria. Diabet Med 2004; 21: 1192-9.Jerums G, Allen TJ, Campbell DJ et al. Melbourne Diabetic Nephropathy Study Group. Long-term renoprotection by perindopril or nifedipine in non-hypertensive patients with type 2 diabetes and microalbuminuria. Diabet Med 2004; 21: 1192-9.Kool MJ, Lustermans FA, Breed JG et al. The influence of perindopril and the diuretic combination amiloride hydrochlorothiazide on the vessel wall properties of large arteries in hypertensive patients. J Hypertens 1995; 13: 839-48.Kool MJ, Lustermans FA, Breed JG et al. The influence of perindopril and the diuretic combination amiloride hydrochlorothiazide on the vessel wall properties of large arteries in hypertensive patients. J Hypertens 1995; 13: 839-48.Poulter NR, Wedel H, Dahlof B et al. ASCOT Investigators. Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA). Lancet 2005; 366.Poulter NR, Wedel H, Dahlof B et al. ASCOT Investigators. Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA). Lancet 2005; 366.Safar ME. Treatment for one year with perindopril: effect on cardiac mass and arterial compliance in essential hypertension. J Hypertens (Suppl.) 1988; 6: S33-9.Safar ME. Treatment for one year with perindopril: effect on cardiac mass and arterial compliance in essential hypertension. J Hypertens (Suppl.) 1988; 6: S33-9.Sihm I, Schroeder AP, Aalkjaer C et al. Normalization of structural cardiovascular changes during antihypertensive treatment with a regimen based on the ACE inhibitor perindopril. Blood Press 1995; 4: 241-8.Sihm I, Schroeder AP, Aalkjaer C et al. Normalization of structural cardiovascular changes during antihypertensive treatment with a regimen based on the ACE inhibitor perindopril. Blood Press 1995; 4: 241-8.Fox KM. EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators/Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet 2003; 362 (9386): 782-8.Fox KM. EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators/Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet 2003; 362 (9386): 782-8.Карпов Ю.А., Шальнова С.А., Деев А.Д. (от имени участников программы ПРЕМЬЕРА). Престариум у больных с артериальной гипертонией и ишемической болезнью сердца (или факторами риска) - безопасное достижение целевого уровня артериального давления (ПРЕМЬЕРА): результаты клинического этапа национальной программы. Кардиология. 2006; 6: 32-8.Карпов Ю.А., Шальнова С.А., Деев А.Д. (от имени участников программы ПРЕМЬЕРА). Престариум у больных с артериальной гипертонией и ишемической болезнью сердца (или факторами риска) - безопасное достижение целевого уровня артериального давления (ПРЕМЬЕРА): результаты клинического этапа национальной программы. Кардиология. 2006; 6: 32-8.Шальнова С.А., Деев А.Д., Карпов Ю.А. (от имени участников программы ПРЕМЬЕРА). Артериальная гипертония и ИБС в амбулаторной практике врача кардиолога. Кардиоваскул. тер. и профилак. 2006; 5 (2): 73-80.Шальнова С.А., Деев А.Д., Карпов Ю.А. (от имени участников программы ПРЕМЬЕРА). Артериальная гипертония и ИБС в амбулаторной практике врача кардиолога. Кардиоваскул. тер. и профилак. 2006; 5 (2): 73-80.Ferrari R. Effects of angiotensin-converting enzyme inhibition with perindopril on left ventricular remodeling and clinical outcome: results of the randomized Perindopril and Remodeling in Elderly with Acute Myocardial Infarction (PREAMI) Study. Arch Intern Med 2006; 166: 659-66.Ferrari R. Effects of angiotensin-converting enzyme inhibition with perindopril on left ventricular remodeling and clinical outcome: results of the randomized Perindopril and Remodeling in Elderly with Acute Myocardial Infarction (PREAMI) Study. Arch Intern Med 2006; 166: 659-66.Cleland JG, Tendera M, Adamus J et al. The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur Heart J 2006; 27: 2338-45.Cleland JG, Tendera M, Adamus J et al. The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur Heart J 2006; 27: 2338-45.Myers MG. A dose-response study of perindopril in hypertension: effects on blood pressure 6 and 24 h after dosing. Perindopril Multicentre Dose-Response Study Group. Can J Cardiol 1996; 12: 1191-6.Myers MG. A dose-response study of perindopril in hypertension: effects on blood pressure 6 and 24 h after dosing. Perindopril Multicentre Dose-Response Study Group. Can J Cardiol 1996; 12: 1191-6.Telejko E. Perindopril-arginine: benefits of a new salt of the ACE inhibitor perindopril. Curr Med Res Opin 2007; 23: 953-60.Telejko E. Perindopril-arginine: benefits of a new salt of the ACE inhibitor perindopril. Curr Med Res Opin 2007; 23: 953-60.
The authors declare that there are no conflicts of interest present.